Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Hemab Therapeutics Holdings, Inc. - Common Stock (NQ:COAG)

44.37 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 3, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	113
Open	44.37
Bid (Size)	23.11 (100)
Ask (Size)	48.88 (100)
Prev. Close	44.37
Today's Range	44.37 - 44.37
52wk Range	23.00 - 55.42
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

August 11, 2026

From Hemab Therapeutics, Inc.

Via GlobeNewswire

Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress

July 14, 2026

From Hemab Therapeutics, Inc.

Via GlobeNewswire

Performance

YTD	+30.5%	+30.5%
1 Month	-4.6%	-4.6%
3 Month	+74.6%	+74.6%
6 Month	+30.5%	+30.5%
1 Year	+30.5%	+30.5%

More News

Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress

July 12, 2026

From Hemab Therapeutics, Inc.

Via GlobeNewswire

Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress

June 26, 2026

From Hemab Therapeutics, Inc.

Via GlobeNewswire

Hemab Therapeutics Details Post-IPO Pipeline Push, Sutacimig Phase III Plans ↗

June 08, 2026

Via MarketBeat

Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

May 27, 2026

From Hemab Therapeutics, Inc.

Via GlobeNewswire

Hemab Therapeutics Reports First Quarter 2026 Financial Results

May 21, 2026

From Hemab Therapeutics, Inc.

Via GlobeNewswire

Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

May 04, 2026

From Hemab Therapeutics, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Hemab Therapeutics Holdings, Inc. - Common Stock publicly traded?

Yes, Hemab Therapeutics Holdings, Inc. - Common Stock is publicly traded.

What exchange does Hemab Therapeutics Holdings, Inc. - Common Stock trade on?

Hemab Therapeutics Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Hemab Therapeutics Holdings, Inc. - Common Stock?

The ticker symbol for Hemab Therapeutics Holdings, Inc. - Common Stock is COAG on the Nasdaq Stock Market

What is the current price of Hemab Therapeutics Holdings, Inc. - Common Stock?

The current price of Hemab Therapeutics Holdings, Inc. - Common Stock is 44.37

When was Hemab Therapeutics Holdings, Inc. - Common Stock last traded?

The last trade of Hemab Therapeutics Holdings, Inc. - Common Stock was at 09/03/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.